AxoGen Inc. | Mutual Funds
Mutual Funds that own AxoGen Inc.
Vanguard Total Stock Market Index Fund
806,292
2.1%
0
0.01%
07/31/2018
Columbia Acorn Fund
759,339
1.98%
420,111
0.62%
03/29/2018
iShares Russell 2000 ETF
697,678
1.82%
-372
0.06%
09/06/2018
Eagle Small Cap Growth Fund
635,364
1.66%
635,364
0.48%
06/29/2018
AB Discovery Growth Fund
471,409
1.23%
85,610
0.79%
07/31/2018
Vanguard Extended Market Index Fund
427,988
1.12%
14,100
0.03%
07/31/2018
Wells Fargo Advantage Emerging Growth Portfolio
342,677
0.89%
-36,500
1.37%
07/31/2018
Dreyfus Opportunistic Small Cap Fund
326,140
0.85%
0
1.13%
04/30/2018
iShares Russell 2000 Growth ETF
322,266
0.84%
0
0.12%
09/06/2018
iShares US Medical Devices ETF
285,222
0.74%
0
0.43%
09/06/2018
| Address |
13631 Progress Boulevard
Alachua Florida 32615
United States
|
|
Employees
|
- |
| Website |
http://www.axogeninc.com |
| Updated |
07/08/2019 |
| AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. |
